These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8544783

  • 1. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation.
    Venkatesan N, Lim J, Bouch C, Marciano D, Davidson MB.
    Metabolism; 1996 Jan; 45(1):92-100. PubMed ID: 8544783
    [Abstract] [Full Text] [Related]

  • 2. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS.
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [Abstract] [Full Text] [Related]

  • 3. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
    Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B.
    Diabetologia; 1993 Oct; 36(10):899-906. PubMed ID: 8243867
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli.
    Weinstein SP, Paquin T, Pritsker A, Haber RS.
    Diabetes; 1995 Apr; 44(4):441-5. PubMed ID: 7698514
    [Abstract] [Full Text] [Related]

  • 5. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK, Wi JK, Youn JH.
    Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
    [Abstract] [Full Text] [Related]

  • 6. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
    Magnan C, Gilbert M, Kahn BB.
    Lipids; 1996 Nov; 31(11):1141-9. PubMed ID: 8934446
    [Abstract] [Full Text] [Related]

  • 7. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.
    Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):707-12. PubMed ID: 9032457
    [Abstract] [Full Text] [Related]

  • 8. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.
    Zhou YP, Grill VE.
    J Clin Invest; 1994 Feb 01; 93(2):870-6. PubMed ID: 8113418
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle.
    Weinstein SP, Wilson CM, Pritsker A, Cushman SW.
    Metabolism; 1998 Jan 01; 47(1):3-6. PubMed ID: 9440469
    [Abstract] [Full Text] [Related]

  • 10. Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats.
    Venkatesan N, Davidson MB, Hutchinson A.
    Metabolism; 1987 Sep 01; 36(9):883-91. PubMed ID: 3306280
    [Abstract] [Full Text] [Related]

  • 11. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Alford F, Vaag A, Handberg A, Beck-Nielsen H.
    Metabolism; 1999 Sep 01; 48(9):1128-35. PubMed ID: 10484052
    [Abstract] [Full Text] [Related]

  • 12. In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution.
    Coderre L, Vallega GA, Pilch PF, Chipkin SR.
    Am J Physiol; 1996 Oct 01; 271(4 Pt 1):E643-8. PubMed ID: 8897851
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS, Al-Saleh E, Al-Mulla F.
    Life Sci; 2005 Sep 30; 77(20):2552-73. PubMed ID: 15936776
    [Abstract] [Full Text] [Related]

  • 14. Regulation of glucose metabolism by free fatty acid availability in septic and nonseptic rats.
    Lang CH, Dobrescu C.
    Circ Shock; 1992 Oct 30; 38(2):91-102. PubMed ID: 1423926
    [Abstract] [Full Text] [Related]

  • 15. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
    Zhou YP, Berggren PO, Grill V.
    Diabetes; 1996 May 30; 45(5):580-6. PubMed ID: 8621007
    [Abstract] [Full Text] [Related]

  • 16. The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice.
    Bryson JM, Cooney GJ, Wensley VR, Phuyal JL, Caterson ID.
    Int J Obes Relat Metab Disord; 1996 Aug 30; 20(8):738-44. PubMed ID: 8856397
    [Abstract] [Full Text] [Related]

  • 17. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
    Sako Y, Grill VE.
    Endocrinology; 1990 Oct 30; 127(4):1580-9. PubMed ID: 1698143
    [Abstract] [Full Text] [Related]

  • 18. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids.
    Cleasby ME, Kelly PA, Walker BR, Seckl JR.
    Endocrinology; 2003 Mar 30; 144(3):999-1007. PubMed ID: 12586777
    [Abstract] [Full Text] [Related]

  • 19. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
    Weinstein SP, Holand A, O'Boyle E, Haber RS.
    Metabolism; 1993 Oct 30; 42(10):1365-9. PubMed ID: 8412752
    [Abstract] [Full Text] [Related]

  • 20. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.
    Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M.
    Hypertension; 2001 Oct 30; 38(4):884-90. PubMed ID: 11641303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.